Naifang Zhang

Compliance Highlights And Strategies In High-Risk Clinical Research Landscape

Strategic Insights For The Localization Of Pharmaceutical And Medical Device Manufacturing In China

Analysis Of China's New Draft Of Drug Regulatory Data Protection Rule: A New Perspective On Innovative Drug Transactions

解读人类遗传资源管理最新问答：人源细胞系、肿瘤异种移植模型（CDX/PDX）、CAR-T治疗材料监管问题